Analysis. Vekuva's measurement of another outlet's report. The reporting is the outlet's; the framing analysis is ours. · The Hindu
Vekuva’s reading of The Hindu’s report
Phage therapy holds promise in fighting against antimicrobial resistance: Dr. Kalyan Chakravarthy
By Sambasiva Rao M.2 min read at The Hindu
In brief
Dr. Kalyan Chakravarthy Koganti, a sepsis and infectious diseases specialist at SHRI Hospital in Guntur, presented research on phage therapy at an international symposium in Hong Kong.
He shared that the therapy selectively targets harmful bacteria without affecting human cells and has shown encouraging results in patients at his center.
The team is collaborating with SRM University and Szeged University in Hungary to advance the therapy's availability in India.
This is an AI-estimated analysis and may not reflect the article's actual intent or the publisher's editorial position.
Read this page in Telugu · Google Translate (opens translate.google.com in a new tab)Machine translation by Google, not checked by Vekuva
At a glance
- Tone: favourable
- Ownership not yet recorded
- Coverage: only The Hindu so farWhat is this?
Published - November 12, 2026 05:05 pm IST - GUNTUR
Andhra Pradesh, Guntur, November 12, 2026: Dr. Kalyan Chakravarthy Koganti, sepsis and infectious diseases specialist at SHRI Hospital, Guntur addressed a symposium organised by a Chinese University in Hong Kong recently. Photo: Arrangement | Photo Credit: Special arrangement
That is the opening of The Hindu’s story. The full report is on their site.
Read the full story at The Hindu (opens in a new tab)